Le Lézard
Classified in: Science and technology, Business
Subject: DIV

SiriusXM Increases Quarterly Cash Dividend By 10%


NEW YORK, Oct. 10, 2019 /PRNewswire/ -- SiriusXM today announced that its Board of Directors declared a quarterly cash dividend of $0.01331 per share of common stock, reflecting an increase of 10% over the previous quarter's dividend. This regular quarterly dividend is payable in cash on November 29, 2019 to stockholders of record at the close of business on November 8, 2019.

SIRIUS XM logo. (PRNewsFoto/SIRIUS XM Radio)

SiriusXM first initiated a regular quarterly dividend in November 2016 at $0.01 per share per quarter, and the company has now increased this dividend by 10% in each of the past three years.

About SiriusXM

Sirius XM Holdings Inc. (NASDAQ: SIRI) is the world's largest audio entertainment company, and the premier programmer and platform for subscription- and advertising-supported audio products. With the recent addition of Pandora, the largest streaming music provider in the U.S., SiriusXM reaches more than 100 million people with its audio products. For more about the new SiriusXM, please go to: www.siriusxm.com.

This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "believe," "intend," "plan," "projection," "outlook" or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

The following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: our substantial competition, which is likely to increase over time; our ability to attract or increase the number of subscribers, which is uncertain; our ability to profitably attract and retain more price-sensitive consumers; failure to protect the security of personal information about our customers; interference to our service from wireless operations; a decline in the effectiveness of our extensive marketing efforts; consumer protection laws and their enforcement; our failure to realize benefits of acquisitions or other strategic initiatives, including the acquisition of Pandora Media, Inc.; unfavorable outcomes of pending or future litigation; the market for music rights, which is changing and subject to uncertainties; our dependence upon the auto industry; general economic conditions; existing or future government laws and regulations could harm our business; failure of our satellites would significantly damage our business; the interruption or failure of our information technology and communications systems; rapid technological and industry changes; failure of third parties to perform; our failure to comply with FCC requirements; modifications to our business plan; our indebtedness; damage to our studios, networks or other three facilities as a result of terrorism or natural catastrophes; our principal stockholder has significant influence over our affairs and over actions requiring stockholder approval and its interests may differ from interests of other holders of our common stock; impairment of our business by third-party intellectual property rights; and changes to our dividend policies which could occur at any time. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found in our Annual Report on Form 10-K for the year ended December 31, 2018 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, in each case, as filed with the Securities and Exchange Commission (the "SEC") and available at the SEC's Internet site (http://www.sec.gov ). The information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.

Source: SiriusXM

Investor Relations contact:

Hooper Stevens
212-901-6718
[email protected]

Chris Leal
212-584-5236
[email protected]

 

SOURCE Sirius XM Holdings Inc.


These press releases may also interest you

at 09:05
Aspen Technology, Inc. , a global leader in industrial software, today introduced AspenTech Strategic Planning for Sustainability Pathwaystm ? a new and unique integrated modelling and optimization solution that aims to guide companies in carbon...

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
The Ceph Foundation, the global community dedicated to fostering the growth and advancement of Ceph, is excited to announce the release of Ceph Squid, which comes with several performance and space efficiency features along with enhanced protocol...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
RapidScale, a Cox Business company, bolsters its cybersecurity offerings with SOC as a Service that includes Managed Detection and Response (MDR), a cutting-edge security solution powered by Proficio. This strategic partnership reinforces...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...



News published on and distributed by: